Laboratories are under intense pressure to reduce costs and improve operational efficiency, all while enhancing quality and maintaining regulatory compliance. XIFIN, Inc. is helping laboratories meet these challenges with the next evolution of its award-winning laboratory information system (LIS), XIFIN LIS 6.
The expanded platform features enhancements that support high complexity, high volume labs, as well as new integrated capabilities available through strategic partners, including artificial intelligence (AI)-powered digital pathology workflow and genomic data interpretation, automated prior authorization, and test utilization decision support. The company is also sharing an update on its role in the American Society of Clinical Pathology’s (ASCP) global initiative, “Partners for Cancer Diagnosis and Treatment in Africa.”
The North American LIS market will reach $869 million by 2022, according to Axiom Market Research and Consulting. While on-premise solutions continue to be the most commonly used systems, remotely hosted or Software as a Service (SaaS)-based solutions are beginning to displace them as lab leaders realize the value that the cloud offers. Increasingly, organizations of all types are turning to cloud-based solutions to add flexibility, and to minimize time and money spent on maintenance of complex hardware and software environments.
XIFIN LIS is specifically designed to meet the varied operational needs and regulatory requirements for almost every kind of diagnostic laboratory. It also supports precision medicine programs by helping labs more easily integrate, communicate and exchange information with other systems, like electronic health records (EHRs) and revenue cycle management (RCM) solutions, to improve patient outcomes.
